Background: To analyze the relationship between HPV infection and early cervical cancer
and postoperative survival outcomes. Methods: A total of 556 women were recruited to …

Background Human papillomavirus (HPV) E6/E7 mRNA tests determine the oncogenic
activity of the virus and represent a good clinical biomarker for predicting the risk of cervical …

Objective To analyze the differences of positive detection rate and copy number of human
papillomavirus (HPV) DNA and E6/E7 mRNA between different grades of cervical lesions …

Objectives Pap smear and high-risk human papillomavirus (HR-HPV) DNA testing are the
most widely applied methods for cervical cancer screening, but both methods are limited by …

Cervical cancer is a commonly-encountered malignant tumor in women. Cervical screening
is particularly important due to early symptoms being deficient in specificity. The main …

Background: The detection of human papillomavirus (HPV) E6/E7 mRNA indicates a risk of
further deterioration in cervical lesions. We explored the clinical value of HPV E6/E7 mRNA …

OBJECTIVES: Current methods for HPV screening rely on the detection of L1 DNA from high
risk genotypes (HRHPV). These assays have very high negative predictive values (~ 99%) …

Human papillomavirus (HPV) is a major cause of cervical cancer, which is the third most
common cancer in women. Human telomerase reverse transcriptase (hTERT) and Ki67 are …

Background: Human papillomavirus (HPV) has been shown to be the major risk factor for the
development of cervical carcinoma, the second most common cancer among women …

Background: The cervical cancer is one of the leading cause of cancer death among women
in developing and developed countries. Screening for cervical cancer is essential as the …